Previous
Poster Home
Next
Assessment of Physician Treatment Preferences for Relapsed or Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL)
07:30am - 03:45pm EDT - April 1, 2023
Information
Resources
Play Recording
https://jnccn.org/view/journal...
Author(s):
Betsy J. Lahue, MPH
, CEO, Alkemi, LLC
Tags:
Outcomes and Health Services Research
Display Label
Action
116-General Poster Sesson
Download Handout